JPS61204196A - フイトスタノ−ル・フエルラ酸誘導体の製造法 - Google Patents
フイトスタノ−ル・フエルラ酸誘導体の製造法Info
- Publication number
- JPS61204196A JPS61204196A JP4372685A JP4372685A JPS61204196A JP S61204196 A JPS61204196 A JP S61204196A JP 4372685 A JP4372685 A JP 4372685A JP 4372685 A JP4372685 A JP 4372685A JP S61204196 A JPS61204196 A JP S61204196A
- Authority
- JP
- Japan
- Prior art keywords
- phytostanol
- ferulic acid
- dissolved
- pyridine
- acid chloride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical class COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 title claims abstract description 13
- 238000004519 manufacturing process Methods 0.000 title claims description 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims abstract description 18
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 claims abstract description 15
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000000203 mixture Substances 0.000 claims abstract description 12
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 claims abstract description 10
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 230000006196 deacetylation Effects 0.000 claims abstract description 8
- 238000003381 deacetylation reaction Methods 0.000 claims abstract description 8
- 229910000033 sodium borohydride Inorganic materials 0.000 claims abstract description 7
- 239000012279 sodium borohydride Substances 0.000 claims abstract description 7
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 claims abstract description 5
- 229940114124 ferulic acid Drugs 0.000 claims abstract description 5
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 claims abstract description 5
- 235000001785 ferulic acid Nutrition 0.000 claims abstract description 5
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 claims abstract description 5
- SFUVLEGIZGPPNN-UHFFFAOYSA-N (2-pyridin-2-ylacetyl) 2-pyridin-2-ylacetate Chemical compound C=1C=CC=NC=1CC(=O)OC(=O)CC1=CC=CC=N1 SFUVLEGIZGPPNN-UHFFFAOYSA-N 0.000 claims abstract description 4
- 238000003756 stirring Methods 0.000 claims abstract description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 18
- 150000001875 compounds Chemical class 0.000 claims description 8
- LGJMUZUPVCAVPU-JFBKYFIKSA-N Sitostanol Natural products O[C@@H]1C[C@H]2[C@@](C)([C@@H]3[C@@H]([C@H]4[C@@](C)([C@@H]([C@@H](CC[C@H](C(C)C)CC)C)CC4)CC3)CC2)CC1 LGJMUZUPVCAVPU-JFBKYFIKSA-N 0.000 claims description 7
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 claims description 7
- LGJMUZUPVCAVPU-HRJGVYIJSA-N stigmastanol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]2(C)CC1 LGJMUZUPVCAVPU-HRJGVYIJSA-N 0.000 claims description 6
- ARYTXMNEANMLMU-UHFFFAOYSA-N 24alpha-methylcholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(C)C(C)C)C1(C)CC2 ARYTXMNEANMLMU-UHFFFAOYSA-N 0.000 claims description 4
- ARYTXMNEANMLMU-ATEDBJNTSA-N campestanol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]2(C)CC1 ARYTXMNEANMLMU-ATEDBJNTSA-N 0.000 claims description 4
- 238000000034 method Methods 0.000 abstract description 16
- 239000007795 chemical reaction product Substances 0.000 abstract description 11
- 239000000126 substance Substances 0.000 abstract description 10
- 238000001816 cooling Methods 0.000 abstract description 6
- IHKNVZISLLDMOR-GQCTYLIASA-N O-acetylferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1OC(C)=O IHKNVZISLLDMOR-GQCTYLIASA-N 0.000 abstract description 5
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract description 2
- 239000000047 product Substances 0.000 abstract description 2
- XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 230000000624 ovulatory effect Effects 0.000 abstract 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 14
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- 230000016087 ovulation Effects 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 230000001939 inductive effect Effects 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical group C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 244000077995 Coix lacryma jobi Species 0.000 description 4
- 235000007354 Coix lacryma jobi Nutrition 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 239000000741 silica gel Substances 0.000 description 4
- 229910002027 silica gel Inorganic materials 0.000 description 4
- 238000010898 silica gel chromatography Methods 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 241000209205 Coix Species 0.000 description 3
- 240000005979 Hordeum vulgare Species 0.000 description 3
- 235000007340 Hordeum vulgare Nutrition 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- 238000005481 NMR spectroscopy Methods 0.000 description 3
- 238000006640 acetylation reaction Methods 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000000921 elemental analysis Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000005187 foaming Methods 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 238000002329 infrared spectrum Methods 0.000 description 3
- 238000004949 mass spectrometry Methods 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 3
- 239000012521 purified sample Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 230000021736 acetylation Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 239000009538 yokuinin Substances 0.000 description 2
- KPCPQHBDENMEIR-WEVVVXLNSA-N (2E)-2-[(4-hydroxy-3-methoxyphenyl)methylidene]-3-oxobutanoyl chloride Chemical compound COC1=CC(\C=C(/C(C)=O)C(Cl)=O)=CC=C1O KPCPQHBDENMEIR-WEVVVXLNSA-N 0.000 description 1
- KQZZEWUGMBIRGR-SCBDLNNBSA-N (E)-3-(4-acetyl-4-hydroxy-3-methoxycyclohexa-1,5-dien-1-yl)prop-2-enoic acid 3-(4-acetyloxy-3-methoxyphenyl)prop-2-enoic acid Chemical compound COC1C=C(\C=C\C(O)=O)C=CC1(O)C(C)=O.COC1=CC(C=CC(O)=O)=CC=C1OC(C)=O KQZZEWUGMBIRGR-SCBDLNNBSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 101150096839 Fcmr gene Proteins 0.000 description 1
- 208000000913 Kidney Calculi Diseases 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010029148 Nephrolithiasis Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000283977 Oryctolagus Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000209056 Secale Species 0.000 description 1
- 235000007238 Secale cereale Nutrition 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 208000006568 Urinary Bladder Calculi Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000000397 acetylating effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- -1 and 1 Chemical compound 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002921 anti-spasmodic effect Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- MOOAHMCRPCTRLV-UHFFFAOYSA-N boron sodium Chemical compound [B].[Na] MOOAHMCRPCTRLV-UHFFFAOYSA-N 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000000434 field desorption mass spectrometry Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000013160 medical therapy Methods 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4372685A JPS61204196A (ja) | 1985-03-07 | 1985-03-07 | フイトスタノ−ル・フエルラ酸誘導体の製造法 |
| US06/831,853 US4897224A (en) | 1985-03-05 | 1986-02-24 | Method for producing ferulyl stanol derivatives |
| EP86102817A EP0203277B1 (en) | 1985-03-05 | 1986-03-04 | Fertility drugs containing coix lacryma-jobi extracts or ferulyl stanol derivatives and/or a phytosterol fatty-acid ester |
| DE8686102817T DE3688001T2 (de) | 1985-03-05 | 1986-03-04 | Fruchtbarkeitsmittel enthaltend extrakte von coix lacryma-jobi oder ferulylstanolderivate und/oder fettsaeure-phytosterolester. |
| CA000503235A CA1271139A (en) | 1985-03-05 | 1986-03-04 | Fertility drug and method of producing the same |
| CA000610993A CA1288421C (en) | 1985-03-05 | 1989-09-11 | Fertility drug and method of producing the same |
| US07/433,289 US5023249A (en) | 1985-03-05 | 1989-11-08 | Fertility drug and method of producing the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4372685A JPS61204196A (ja) | 1985-03-07 | 1985-03-07 | フイトスタノ−ル・フエルラ酸誘導体の製造法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61204196A true JPS61204196A (ja) | 1986-09-10 |
| JPH0127080B2 JPH0127080B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1989-05-26 |
Family
ID=12671791
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP4372685A Granted JPS61204196A (ja) | 1985-03-05 | 1985-03-07 | フイトスタノ−ル・フエルラ酸誘導体の製造法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS61204196A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012518681A (ja) * | 2009-02-25 | 2012-08-16 | カウンスィル オブ サイエンティフィック アンド インダストリアル リサーチ | フィトステリルフェルレートの製造方法 |
-
1985
- 1985-03-07 JP JP4372685A patent/JPS61204196A/ja active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2012518681A (ja) * | 2009-02-25 | 2012-08-16 | カウンスィル オブ サイエンティフィック アンド インダストリアル リサーチ | フィトステリルフェルレートの製造方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0127080B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1989-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kuzuhara et al. | Syntheses with partially benzylated sugars. VIII. Substitution at carbon-5 in aldose. The synthesis of 5-O-methyl-D-glucofuranose derivatives | |
| SU902666A3 (ru) | Способ получени плевромутилиновых гликозидных производных | |
| EP1414775B1 (en) | Bicyclic cannabinoid | |
| JPS5965100A (ja) | 新規アミノステロイド | |
| US4073935A (en) | Substituted propanol-(2)-derivatives and their nicotinic acid esters, and process for their preparation, and the use thereof as hypolipemic drugs | |
| US4579961A (en) | Organogermanium compounds having both hydrophilicity and lipophilicity and process for producing the same | |
| JPS6345293A (ja) | シアロシルセラミド類及びその製造方法 | |
| CH621803A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| Cox et al. | The synthesis of methyl 4-O-(4-O-α-d-galactopyranosyl-β-d-galactopyranosyl)-β-d-glucopyranoside: The methyl β-glycoside of the trisaccharide related to Fabry's disease | |
| NO750294L (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| JPS61204196A (ja) | フイトスタノ−ル・フエルラ酸誘導体の製造法 | |
| JPS61129145A (ja) | ヒドロキノン誘導体及びその製造方法 | |
| JPS5935904B2 (ja) | 新規な化合物の製造方法 | |
| SATO et al. | Chemistry of the Spiroaminoketal Side Chain of Solasodine and Tomatidine. VI. 1 The Beckmann Rearrangement of the Oximino Derivatives | |
| CAMPBELL et al. | STUDIES ON γ-PYRONES. II. SYNTHESIS OF 4-PIPERIDINOLS FROM PYRONES1 | |
| Konieczny et al. | Reductive methylation of polycyclic aromatic quinones | |
| US4301276A (en) | Synthesis of daunosamine hydrochloride and intermediates used in its preparation | |
| Roberti et al. | Preparation of 3, 4-Dimethoxyphenyl-and 4-Hydroxy-3-methoxyphenylalkylcarbinols | |
| CN111484417B (zh) | 一种卤泛曲林盐酸盐的制备方法 | |
| US3014963A (en) | Process of producing mevalonic acid and its intermediates | |
| US3984461A (en) | 3-0-(Beta-carbobenzyloxypropionyl)-11-oxo-18-beta-olean-12-en-30-oic acid | |
| US3242168A (en) | Alkaloids from plants of the genus funtumia | |
| US5504221A (en) | Method for resolving racemic compounds | |
| Gensler et al. | Synthesis of 6-benzyl-3-oxo-6-azabicyclo [3.2. 1] octane | |
| Wolfrom et al. | Two Ketoöctoses from the D-Galaheptonic Acids |